摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3aR,4R,6R,6aR)-4-(6-amino-2-methylsulfinylpurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl ditert-butyl phosphate | 436847-43-7

中文名称
——
中文别名
——
英文名称
[(3aR,4R,6R,6aR)-4-(6-amino-2-methylsulfinylpurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl ditert-butyl phosphate
英文别名
——
[(3aR,4R,6R,6aR)-4-(6-amino-2-methylsulfinylpurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl ditert-butyl phosphate化学式
CAS
436847-43-7
化学式
C22H36N5O8PS
mdl
——
分子量
561.596
InChiKey
HYNFAQPUWUXLOG-KUUOUUIGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    37
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    178
  • 氢给体数:
    1
  • 氢受体数:
    13

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [(3aR,4R,6R,6aR)-4-(6-amino-2-methylsulfinylpurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl ditert-butyl phosphate 在 DOWEX 50WX8-200 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以3 mg的产率得到phosphoric acid mono[(2R,3R,4S,5R)-5-(6-amino-2-methylsulfinyl-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-ylmethyl]ester
    参考文献:
    名称:
    Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation:  Enhanced Stability and Potency as P2Y1 Receptor Agonists
    摘要:
    Preference for the Northern (N) ring conformation of the ribose moiety of nucleotide 5'-triphosphate agonists at P2Y(1), P2Y(2), P2Y(4), and P2Y(11) receptors, but not P2Y(6) receptors, was established using a ring-constrained methanocarba (a 3.1.0-bicyclohexane) ring as a ribose substitute (Kim et al. J. Med. Chem. 2002, 45, 208-218.). We have now combined the ring-constrained (N)-methanocarba modification of adenine nucleotides with other functionalities known to enhance potency at P2 receptors. The potency of the newly synthesized analogues was determined in the stimulation of phospholipase C through activation of turkey erythrocyte P2Y, or human P2Y, and P2Y2 receptors stably expressed in astrocytoma cells. An (N)methanocarba-2-methylthio-ADP analogue displayed an EC50 at the hP2Y(1) receptor of 0.40 nM and was 55-fold more potent than the corresponding triphosphate and 16-fold more potent than the riboside 5'-diphosphate. 2-Cl-(N)-methanocarba-ATP and its N-6-Me analogue were also highly selective, full agonists at P2Y, receptors. The (N)-methanocarba-2-methylthio and 2-chloromonophosphate analogues were full agonists exhibiting micromolar potency at P2Y(1) receptors, while the corresponding ribosides were inactive. Although beta,y-methylene-ATP was inactive at P2Y receptors beta,y-methylene-(N)-methanocarba-ATP was a potent hP2Y1 receptor agonist with an EC50 of 160 nM and was selective versus hP2Y(2) and hP2Y(4) receptors. The rates of hydrolysis of Northern (N) and Southern (S) methanocarba analogues of AMP by rat 5'-ectonucleotidase were negligible. The rates of hydrolysis of the corresponding triphosphates by recombinant rat NTPDase 1 and 2 were studied. Both isomers were hydrolyzed by NTPDase 1 at about half the rate of ATP hydrolysis. The (N) isomer was hardly hydrolyzed by NTPDase 2, while the (S) isomer was hydrolyzed at one-third of the rate of ATP hydrolysis. This suggests that new, more stable and selective nucleotide agonists may be designed on the basis of the (N)-conformation, which greatly enhanced potency at P2Y, receptors.
    DOI:
    10.1021/jm010538v
  • 作为产物:
    参考文献:
    名称:
    Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation:  Enhanced Stability and Potency as P2Y1 Receptor Agonists
    摘要:
    Preference for the Northern (N) ring conformation of the ribose moiety of nucleotide 5'-triphosphate agonists at P2Y(1), P2Y(2), P2Y(4), and P2Y(11) receptors, but not P2Y(6) receptors, was established using a ring-constrained methanocarba (a 3.1.0-bicyclohexane) ring as a ribose substitute (Kim et al. J. Med. Chem. 2002, 45, 208-218.). We have now combined the ring-constrained (N)-methanocarba modification of adenine nucleotides with other functionalities known to enhance potency at P2 receptors. The potency of the newly synthesized analogues was determined in the stimulation of phospholipase C through activation of turkey erythrocyte P2Y, or human P2Y, and P2Y2 receptors stably expressed in astrocytoma cells. An (N)methanocarba-2-methylthio-ADP analogue displayed an EC50 at the hP2Y(1) receptor of 0.40 nM and was 55-fold more potent than the corresponding triphosphate and 16-fold more potent than the riboside 5'-diphosphate. 2-Cl-(N)-methanocarba-ATP and its N-6-Me analogue were also highly selective, full agonists at P2Y, receptors. The (N)-methanocarba-2-methylthio and 2-chloromonophosphate analogues were full agonists exhibiting micromolar potency at P2Y(1) receptors, while the corresponding ribosides were inactive. Although beta,y-methylene-ATP was inactive at P2Y receptors beta,y-methylene-(N)-methanocarba-ATP was a potent hP2Y1 receptor agonist with an EC50 of 160 nM and was selective versus hP2Y(2) and hP2Y(4) receptors. The rates of hydrolysis of Northern (N) and Southern (S) methanocarba analogues of AMP by rat 5'-ectonucleotidase were negligible. The rates of hydrolysis of the corresponding triphosphates by recombinant rat NTPDase 1 and 2 were studied. Both isomers were hydrolyzed by NTPDase 1 at about half the rate of ATP hydrolysis. The (N) isomer was hardly hydrolyzed by NTPDase 2, while the (S) isomer was hydrolyzed at one-third of the rate of ATP hydrolysis. This suggests that new, more stable and selective nucleotide agonists may be designed on the basis of the (N)-conformation, which greatly enhanced potency at P2Y, receptors.
    DOI:
    10.1021/jm010538v
点击查看最新优质反应信息

文献信息

  • Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation:  Enhanced Stability and Potency as P2Y<sub>1</sub> Receptor Agonists
    作者:R. Gnana Ravi、Hak Sung Kim、Jörg Servos、Herbert Zimmermann、Kyeong Lee、Savitri Maddileti、José L. Boyer、T. Kendall Harden、Kenneth A. Jacobson
    DOI:10.1021/jm010538v
    日期:2002.5.1
    Preference for the Northern (N) ring conformation of the ribose moiety of nucleotide 5'-triphosphate agonists at P2Y(1), P2Y(2), P2Y(4), and P2Y(11) receptors, but not P2Y(6) receptors, was established using a ring-constrained methanocarba (a 3.1.0-bicyclohexane) ring as a ribose substitute (Kim et al. J. Med. Chem. 2002, 45, 208-218.). We have now combined the ring-constrained (N)-methanocarba modification of adenine nucleotides with other functionalities known to enhance potency at P2 receptors. The potency of the newly synthesized analogues was determined in the stimulation of phospholipase C through activation of turkey erythrocyte P2Y, or human P2Y, and P2Y2 receptors stably expressed in astrocytoma cells. An (N)methanocarba-2-methylthio-ADP analogue displayed an EC50 at the hP2Y(1) receptor of 0.40 nM and was 55-fold more potent than the corresponding triphosphate and 16-fold more potent than the riboside 5'-diphosphate. 2-Cl-(N)-methanocarba-ATP and its N-6-Me analogue were also highly selective, full agonists at P2Y, receptors. The (N)-methanocarba-2-methylthio and 2-chloromonophosphate analogues were full agonists exhibiting micromolar potency at P2Y(1) receptors, while the corresponding ribosides were inactive. Although beta,y-methylene-ATP was inactive at P2Y receptors beta,y-methylene-(N)-methanocarba-ATP was a potent hP2Y1 receptor agonist with an EC50 of 160 nM and was selective versus hP2Y(2) and hP2Y(4) receptors. The rates of hydrolysis of Northern (N) and Southern (S) methanocarba analogues of AMP by rat 5'-ectonucleotidase were negligible. The rates of hydrolysis of the corresponding triphosphates by recombinant rat NTPDase 1 and 2 were studied. Both isomers were hydrolyzed by NTPDase 1 at about half the rate of ATP hydrolysis. The (N) isomer was hardly hydrolyzed by NTPDase 2, while the (S) isomer was hydrolyzed at one-third of the rate of ATP hydrolysis. This suggests that new, more stable and selective nucleotide agonists may be designed on the basis of the (N)-conformation, which greatly enhanced potency at P2Y, receptors.
查看更多

同类化合物

黄苷5'-(四氢三磷酸酯)三钠盐 黄苷3',5'-环单磷酸酯 黄苷-5'-三磷酸酯 鸟苷酸 鸟苷三磷酸锂 鸟苷3'-(三氢二磷酸酯),5'-(三氢二磷酸酯) 鸟苷2’,3’-环单磷酸酯三乙胺盐 鸟苷-5’-二磷酸 鸟苷-3',5'-环单硫代磷酸酯 Rp-异构体钠盐 鸟苷 5'-(四氢三磷酸酯-P''-32P) 鸟苷 5'-(四氢 5-硫代三磷酸酯) 鸟嘌呤核糖苷-3’,5’-环磷酸酯 铁-腺苷三磷酸酯络合物 钠(4aR,6R,7R,7aR)-6-{6-氨基-8-[(4-氯苯基)硫基]-9H-嘌呤-9-基}-7-甲氧基四氢-4H-呋喃并[3,2-d][1,3,2]二氧杂环己膦烷-2-醇2-氧化物水合物(1:1:1) 辅酶A二硫醚八锂盐 辅酶 A 钠盐 水合物 辅酶 A 葡甲胺环腺苷酸 苯基新戊基酮三甲基甲硅烷基烯醇醚 苯乙酰胺,a-羟基-3,5-二硝基- 腺苷酸基琥珀酸 腺苷酰基亚胺二磷酸四锂盐 腺苷酰-(2'-5')-腺苷酰-(2'-5')腺苷 腺苷焦磷酸酯-葡萄糖 腺苷四磷酸吡哆醛 腺苷三磷酸酯铜盐 腺苷三磷酸酯gamma-4-叠氮基苯胺 腺苷三磷酸酯-gamma-4-(N-2-氯乙基-N-甲基氨基)苄基酰胺 腺苷三磷酸酯-gamma 酰胺 腺苷三磷酸酯 gamma-苯胺 腺苷三磷酸吡哆醛 腺苷5'-五磷酸酯 腺苷5'-三磷酸酯3'-二磷酸酯 腺苷5'-[氢[[羟基(膦酰氧基)亚膦酰]甲基]膦酸酯] 腺苷5'-O-(2-硫代三磷酸酯) 腺苷5'-(氢((羟基((羟基(膦酰氧基)亚膦酰)氧基)亚膦酰)甲基)膦酸酯) 腺苷5'-(三氢二磷酸酯)镁盐 腺苷5'-(O-甲基磷酸酯) 腺苷3`,5`-环内单磷酸酯乙酰氧甲基酯 腺苷3-磷酸酯5-二磷酸酯 腺苷1-氧化物磷酸酯(1:3) 腺苷-5′-三磷酸二钠盐,(无钙) 腺苷-5′-三磷酸二钠盐(ATP) 腺苷-5'-二磷酸二钠盐 腺苷-5'-二磷酸三锂盐 腺苷-5'-O-(1-硫代三磷酸酯) 腺苷-3'-5'-环磷酸 腺苷-3',5'-环状单磷酸钠水合物 腺苷-2’,3’-环磷酸 腺苷,磷酸)2'-(2-氨基苯酸)(9CI)氢环3',5'-(